Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus

G. Kirtschig, K. Becker, A. Günthert, D. Jasaitiene, S. Cooper, C. C. Chi, A. Kreuter, K. K. Rall, W. Aberer, S. Riechardt, F. Casabona, J. Powell, F. Brackenbury, R. Erdmann, M. Lazzeri, G. Barbagli, F. Wojnarowska

Research output: Contribution to journalArticlepeer-review


Lichen sclerosus (LS) is an inflammatory skin disease that usually involves the anogenital area. All patients with symptoms or signs suspicious of lichen sclerosus should be seen at least once initially by a physician with a special interest in the disease in order to avoid delay in diagnosis, as early treatment may cure the disease in some and reduce or prevent scarring. The diagnosis is made clinically in most cases. Biopsies should only be performed under certain circumstances. The gold standard for treatment remains potent to very potent topical steroids; however, mild and moderate disease in boys and men may be cured by circumcision. Certain triggers should be avoided. http://www.euroderm.org/images/stories/guidelines/2014/S3-Guideline-on-Lichen-sclerosus.pdf http://www.awmf.org/fachgesellschaften/mitgliedsgesellschaften/visitenkarte/fg/deutsche-gesellschaft-fuer-gynaekologie-und-geburtshilfe-dggg.html.

Original languageEnglish
Pages (from-to)e1-e43
JournalJournal of the European Academy of Dermatology and Venereology
Issue number10
Publication statusPublished - Oct 1 2015

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases


Dive into the research topics of 'Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus'. Together they form a unique fingerprint.

Cite this